prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - FINAL DIAGNOSIS: PART 1: RIGHT SENTINEL LYMPH NODE #1, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR TUMOR (0/1). PART 2: RIGHT NONSENTINEL LYMPH NODE, BIOPSY-. ONE LYMPH NODE NEGATIVE FOR TUMOR (0/1). PART 3: RIGHI BREAST, LUMPECTOMY -. A. INFILTRATING DUCT CARCINOMA, 0.9 X 0.8 X 0.6 CM. B. NOTTINGHAM SCORE 6/9 (TUBULES 3, NUCLEI 2, MITOSIS 1). C. NO LYMPHOVASCULAR INVASION IDENTIFIED. D. DUCTAL CARCINOMA IN SITU, SOLID TYPE, NUCLEAR GRADE 2, COMPRISING 5% OF INVASIVE TUMOR. E. SURGICAL MARGINS NEGATIVE FOR INFILTRATING DUCT CARCINOMA AND DUCTAL CARCINOMA IN. SITU. F. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITE. G. TUMOR IS ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR POSITIVE AND HER-2/NEU. WEAKLY POSITIVE (SCORE 2+). NO AMPLIFICATION OF HER-2/NEU GENE WAS IDENTIFIED. H. FIBROCYSTIC CHANGES WITH MICROCALCIFICATIONS. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 0.9 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: TUMOR TYPE, IN SITU: Solid, Percent of tumor occupied by in situ component: 5 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 0 mm. NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1b. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.

expanded version (tokens=1115) : 
 The breast pathology report lists information regarding a biopsy and lumpectomy of the right breast. Here are the main points from the report:

1. Histological Classification:
- Infiltrating duct carcinoma
- Ductal carcinoma in situ (DCIS), solid type

2. Subtype:
- Not specified

3. Necrosis:
- Not mentioned

4. Tumor Infiltrating Lymphocytes:
- Not mentioned

5. Histological Grade:
- Nottingham score 6/9 (Tubules 3, nuclei 2, mitosis 1)
- Nuclear grade 2

6. Lymphovascular invasion:
- No lymphovascular invasion identified

7. Calcification:
- Fibrocystic changes with microcalcifications
- In situ component occupies 5% of the tumor

8. Receptor Status:
- Estrogen receptor positive
- Progesterone receptor positive
- HER-2/neu weakly positive (score 2+)
- No amplification of HER-2/neu gene was identified

9. Ancillary Testing Results:
- Surgical margins negative for infiltrating duct carcinoma and DCIS
- Changes consistent with previous core biopsy site

In summary, the report reveals a diagnosis of infiltrating duct carcinoma and DCIS in the right breast. The histological grade is intermediate, and there is no lymphovascular invasion identified. The tumor is positive for estrogen and progesterone receptors, and weakly positive for HER

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1256) : 
 Report: The biopsy identified infiltrating duct carcinoma and ductal carcinoma in situ, solid type comprising 5% of the tumor. The histological grading revealed Nottingham score 6/9, nuclear grade 2 and no lymphovascular invasion was detected. The surgical margins were negative. The tumor was positive for estrogen and progesterone receptors. HER-2/neu was weakly positive (score 2+) and no amplification of the gene was identified.

